BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1478785)

  • 1. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.
    Mulichak AM; Hui JO; Tomasselli AG; Heinrikson RL; Curry KA; Tomich CS; Thaisrivongs S; Sawyer TK; Watenpaugh KD
    J Biol Chem; 1993 Jun; 268(18):13103-9. PubMed ID: 8514751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine.
    Baldwin ET; Bhat TN; Gulnik S; Liu B; Topol IA; Kiso Y; Mimoto T; Mitsuya H; Erickson JW
    Structure; 1995 Jun; 3(6):581-90. PubMed ID: 8590019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
    J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.
    Jaskólski M; Tomasselli AG; Sawyer TK; Staples DG; Heinrikson RL; Schneider J; Kent SB; Wlodawer A
    Biochemistry; 1991 Feb; 30(6):1600-9. PubMed ID: 1993177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
    Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
    Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
    Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
    J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compounds.
    Weber J; Majer P; Litera J; Urban J; Soucek M; Vondrásek J; Konvalinka J; Novek P; Sedlácek J; Strop P; Kräusslich HG; Pichová I
    Arch Biochem Biophys; 1997 May; 341(1):62-9. PubMed ID: 9143353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
    Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
    J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
    Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A
    Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR
    Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
    Swain AL; Miller MM; Green J; Rich DH; Schneider J; Kent SB; Wlodawer A
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8805-9. PubMed ID: 2247451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
    Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
    Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.
    Beck ZQ; Lin YC; Elder JH
    J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate.
    Bláha I; Nemec J; Tözsér J; Oroszlan S
    Int J Pept Protein Res; 1991 Nov; 38(5):453-8. PubMed ID: 1802863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor.
    Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
    Nat Struct Biol; 1994 Aug; 1(8):552-6. PubMed ID: 7664084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
    Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.